Des Jarlais D C, Paone D, Friedman S R, Peyser N, Newman R G
Beth Israel Medical Center, New York City, USA.
Am J Public Health. 1995 Nov;85(11):1577-84. doi: 10.2105/ajph.85.11.1577.
One third of all cases of the acquired immunodeficiency syndrome (AIDS) in the United States are associated with the injection of illicit drugs. There is mounting evidence for the effectiveness of syringe exchange programs in reducing human immunodeficiency virus (HIV) risk behavior and HIV transmission among injection drug users. Expansion of syringe exchange would require increased public funding and undoubtedly would include government regulation of syringe exchanges. An analogy is drawn with the present system of regulation of methadone maintenance treatment programs and possible regulation of syringe exchange programs. Specific recommendations are offered to reduce the likelihood of repeating the regulatory problems of methadone maintenance treatment in future regulation of syringe exchange programs.
在美国,三分之一的后天免疫机能丧失综合症(艾滋病)病例与注射非法药物有关。越来越多的证据表明,针头交换项目在减少注射吸毒者感染人类免疫缺陷病毒(HIV)的风险行为及HIV传播方面是有效的。扩大针头交换项目需要增加公共资金投入,而且无疑将包括政府对针头交换的监管。文章将其与当前美沙酮维持治疗项目的监管体系以及针头交换项目可能的监管进行了类比。文中还给出了具体建议,以降低未来针头交换项目监管中再次出现美沙酮维持治疗监管问题的可能性。